Clinical trial
Pycnogenol for the Treatment of Lymphedema
NCT00214032 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214032 |
|---|---|
| Title | Pycnogenol for the Treatment of Lymphedema |
| Official title | Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphedema |
| Intervention type | Drug |
| Interventions | Pycnogenol, Placebo |
| Enrollment | 2 |
| Start date | May 1, 2002 |
| Primary completion | Nov 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: